Copertina

Immune Response and Protective Efficacy of β-Glucan and Alkoxyglycerol as Adjuvant in Streptococcus agalactiae Formalin-Inactivated Vaccine in Nile Tilapia (Oreochromis niloticus).

Fuente: PubMed

Salvato in:

Dettagli Bibliografici
Autori principali:	Guha, Ritam, Nandhakumar, K, Byadgi, Omkar Vijay, Chen, Shih-Chu, Elumalai, Preetham
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Journal of fish diseases 2025
Soggetti:	Animals Fish Diseases Cichlids Streptococcus agalactiae beta-Glucans Streptococcal Infections Adjuvants, Immunologic Vaccines, Inactivated Streptococcal Vaccines Glycerol Formaldehyde
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Analysis of the efficacy of two molecular adjuvants, flagellin and IFN-γ, on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
di: Lakshmi, Sreeja, et al.
Pubblicazione: (2025)

Protective efficacy of Interferon-γ and β-glucan adjuvanted formalin killed vaccines in Nile tilapia against Edwardsiella tarda infection.
di: Guha, Ritam, et al.
Pubblicazione: (2025)

Immunopotentiating effects of recombinant TNFα in formalin-killed Streptococcus parauberis vaccine for starry flounder.
di: Sohn, Min-Young, et al.
Pubblicazione: (2026)

Sequential nanoimmersion and hydrogel-based multivalent vaccination induce durable multilayered immunity against four bacterial pathogens in Nile tilapia (Oreochromis niloticus).
di: Kumwan, Benchawan, et al.
Pubblicazione: (2026)

Mucoadhesive chitosan-based nano vaccine as promising immersion vaccine against Edwardsiella tarda challenge in Nile tilapia (Oreochromis niloticus).
di: Nandhakumar, et al.
Pubblicazione: (2025)

Development and immunological evaluation of a Streptococcus suis serotype 2 capsular polysaccharide conjugate vaccine.
di: Zhong, Yingjie, et al.
Pubblicazione: (2026)

Evaluation of the efficacy of microencapsulatedscaffold against Edwardsiellatardain oral vaccinated Nile tilapia (Oreochromis niloticus).
di: Elumalai, Preetham, et al.
Pubblicazione: (2025)

Comparative analysis of T-cell immunity between Streptococcus agalactiae susceptible and resistant tilapia (Oreochromis niloticus).
di: Zhang, Jiansong, et al.
Pubblicazione: (2024)

Identification, molecular typing, antimicrobial susceptibility, and experimental pathogenicity of Streptococcus agalactiae isolated from Tilapia.
di: Guha, Ritam, et al.
Pubblicazione: (2026)

Effect of dietary carrageenan supplementation on growth performance, digestive enzyme and antioxidant enzyme activity, immune gene expression, and capacity against S. agalactiae of Nile tilapia (Oreochromis niloticus).
di: Ramachandran, Ishwarya, et al.
Pubblicazione: (2026)

Comparative transcriptome analysis reveals a serotype-specific immune response in Nile tilapia () infected with .
di: Appel, Renan José Casarotto, et al.
Pubblicazione: (2024)

Protection of Nile tilapia against Aeromonas hydrophila using a cobalt oxide nanoparticle vaccine containing inactivated whole cell bacteria.
di: Lakshmi, Sreeja, et al.
Pubblicazione: (2025)

IL-7 enhances the protective efficacy of inactivated grass carp reovirus vaccine as adjuvant in grass carp (Ctenopharyngodon idella).
di: Wang, Shijie, et al.
Pubblicazione: (2026)

Effect of dietary egg lysozyme on improved growth performance, intestinal health, antioxidant capacity, and disease resistance in hybrid red tilapia (Oreochromis niloticus x O. mossambicus).
di: Radwan, Mahmoud, et al.
Pubblicazione: (2025)

CXCL20a promotes the immune protection of an inactivated vaccine against grass carp reovirus infection in grass carp (Ctenopharyngodon idella).
di: Lu, Yizhong, et al.
Pubblicazione: (2026)

Safety, immunogenicity, efficacy and effectiveness of inactivated influenza vaccines in healthy pregnant women and children under 5 years: An evidence-based clinical review
di: Bansal, Amit, et al.
Pubblicazione: (2021)

Transcriptome analysis of tilapia streptococcus agalactiae in response to baicalin.
di: Huang, Qing-Qin, et al.
Pubblicazione: (2025)

A modified IL-7 enhances the immune response to an inactivated GCRV-II vaccine in grass carp (Ctenopharyngodon idella).
di: Wang, Shijie, et al.
Pubblicazione: (2026)

Vaccines as a strategic approach to combat Vibrio parahaemolyticus and control of early mortality syndrome sin shrimp aquaculture: A comprehensive review.
di: Sen, Bipul Kumar, et al.
Pubblicazione: (2026)

Efficacy of a novel oral bivalent vaccine with fucoidan as adjuvant against Aeromonas hydrophila and Edwardsiella tarda infections in Nile tilapia aquaculture.
di: Guha, Ritam, et al.
Pubblicazione: (2026)

Unveiling Complete Genome of Streptococcus agalactiae from Malaysian Aquaculture: A Closer Look at Molecular Characteristics and Phylogenomic.
di: Zainal Fithri, Helmi Husaini, et al.
Pubblicazione: (2026)

DL-propargylglycine reverses beta-lactam resistance in Streptococcus agalactiae.
di: Chen, Xuan-Wei, et al.
Pubblicazione: (2026)

Recombinant phage-display monoclonal antibody against starry flounder (Platichthys stellatus) IgM enables quantitative ELISA for vaccine-induced humoral responses.
di: Sohn, Min-Young, et al.
Pubblicazione: (2026)

Identification of an isg15 gene in Nile tilapia (Oreochromis niloticus) and analysis of its role in immune response modulation.
di: Wang, Yan, et al.
Pubblicazione: (2026)

Oral adjuvanted Vibrio vaccine enhances antibody production and lysozyme activity in the serum and mucus of marine-cultured red hybrid tilapia (Oreochromis sp.) against V. harveyi and V. alginolyticus.
di: Manchanayake, Tilusha, et al.
Pubblicazione: (2025)

An oral multivalent fusion vaccine based on antigenic fragment VP56 and FlaC adjuvant confers effective protection against grass carp reovirus.
di: Tang, Bo, et al.
Pubblicazione: (2026)

Comparison of the adjuvant effect of propolis and Freund on the efficacy of Aeromonas hydrophila vaccine in common carp (Cyprinus carpio)
di: Alishahi, M., et al.
Pubblicazione: (2019)

Vaccination of rainbow trout against Streptococcus iniae infection: comparison of different routes of administration and different vaccines
di: Soltani, M., et al.
Pubblicazione: (2007)

Pathogen-driven modulation of eight STATs in Cromileptes altivelis: Comparative analysis from homeostasis to immune activation.
di: Zhang, Panpan, et al.
Pubblicazione: (2026)

Antibody Responses in Pigs Induced by Inactivated Vaccine Against Streptococcus suis Formulated with Montanide ISA 201 and Montanide Gel 01 Adjuvants
di: Upaditha Adresya Kaler, I Gede Bagas
Pubblicazione: (2025)

Development and characterization of an innovative Flavobacterium oreochromis antigen-encapsulated hydrogel bead for enhancing oral vaccine delivery in hybrid red tilapia (Oreochromis spp.).
di: Thangsunan, Patcharapong, et al.
Pubblicazione: (2025)

Arachidonic acid reverses microplastic-induced macrophage dysfunction in teleost fish.
di: Cao, Yun-Chao, et al.
Pubblicazione: (2026)

Dietary Astragalus polysaccharides enhance potency of inactivated Pseudomonas plecoglossicida vaccine in large yellow croaker (Larimichthys crocea).
di: Song, Yueyang, et al.
Pubblicazione: (2025)

First identification of nuclear factor kappa B inhibitor delta (NFKBID) in Platichthys stellatus: Molecular cloning and expression patterns.
di: Ji, Chae-Yeong, et al.
Pubblicazione: (2026)

Characterisation of the noble crayfish immune response to oomycete-derived immunostimulants.
di: Tarandek, Anita, et al.
Pubblicazione: (2025)

Restoring High Vaccine Coverage in Brazil: Successes and Challenges
di: Fernandes, Eder Gatti, et al.
Pubblicazione: (2023)

CLINICAL CHARACTERISTICS AND REGIONAL FEATURES OF STREPTOCOCCAL TONSILLOPHARYNGITIS AMONG CHILDREN IN SURXONDARYO REGION
di: Xolboyeva Farangiz Rustam qizi
Pubblicazione: (2026)

Streptococcus agalactiae, medios de conservación accesibles a laboratorios de diagnóstico de baja y mediana complejidad
di: Margarita Ester Laczeski
Pubblicazione: (2013)

Detección y caracterización de Streptococcus agalactiae en muestras para urocultivo
di: José Viegas Caetano
Pubblicazione: (2004)

A study on determining the views of people on the COVID-19 vaccine
di: Tengilimoğlu, Dilaver, et al.
Pubblicazione: (2025)